Thursday, December 31, 2015

The Bowser Report – Daily Mover Alert December 30

Today, The Bowser Report issued a daily mover alert on Direct Insite (DIRI) and CPS Technologies (CPSH), both of which gained more than 10% today.

For the third time in as many days, DIRI moved more than 10%. Yesterday and today, the stock posted +20% swings, falling 23.57% yesterday. As we noted in our Dec. 29 alert, volatility is the norm for DIRI.

Rated an 8, this company is one to consider purchasing at the low end of its volatile moves. Do so speculatively, however, as this company has not been a model of consistency in earnings growth, or share price for that matter.

Like DIRI, CPSH is known to be fairly volatile. Over the past month, the stock has been on the rise despite averaging little volume.

Currently rated 7 and in Category 3, CPSH is not a buy right now. The company has not been able to produce consistent results, and its shares have put investors through a roller coaster ride over the past year as a result.

Don’t open any new positions in CPSH. If you currently have a position, follow the Game Plan, but don’t expect this stock to move without consistent earnings growth.

To learn more about The Bowser Report, visit https://thebowserreport.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Wednesday, December 30, 2015

Giggles N’ Hugs, Inc. (GIGL) Serving Growing Families Needed Nutrition and Themed Entertainment

Whatever party theme captures your child’s imagination, Giggles N’ Hugs (OTCQB: GIGL) has it covered. The Los Angeles-based company serves up a magical mix of nutritional menu offerings with themes such as superheroes for both boys and girls, princess, pirate, mermaid, cartoon pups, jungle, dinosaur, rock star and many more.

The company’s start in 2010 was due to Dorsa and Joey Parsi realizing there were no practical places to take their daughter where the establishment truly catered to the needs of young children. It was at this point that the couple began to wonder why that was the case.

It became strikingly apparent to the Parsi’s that all of the ‘kid friendly’ restaurants offered only adult-sized surroundings from furniture to utensils and, worse yet, greasy and unhealthy menu selections. Like any conscientious mother, Mrs. Parsi was always thinking of ways to make life more fun for her daughter while making it a little easier for herself.

At Giggles N’ Hugs, the ‘going out to dinner experience’ no longer means compromising adult standards for those of children. All of the food at Giggles N’ Hugs is made with the freshest quality ingredients on the market. The company offers a variety of organic, healthy food, which, in turn, provides parents with the peace of mind that their children are eating food that is healthy for them. By weaving nutritional menu offerings in with customized party themes targeted to a child’s imagination, the company finds itself occupying a niche poised for shareholder value and long term growth.

Giggles N Hugs, Inc. owns and operates kid-friendly restaurants in California with play areas for children 10 years old and younger. The company owns and operates a restaurant in the Westfield Mall in Century City, a restaurant in the Westfield Topanga shopping center in Woodland Hills, and a restaurant in the Glendale Galleria in Glendale, California. Founded in 2010, the company is based in Los Angeles, California.

For more information, please visit www.gigglesnhugs.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Nutra Pharma Corporation (NPHC) CEO Publishes Letter to Shareholders

Earlier today, Nutra Pharma Corporation (OTCQB: NPHC), the company behind innovative pharmaceutical products such as Nyloxin® and Pet Pain-Away, released a letter to shareholders. In the letter, Rik J. Deitsch, the company’s chief executive officer, gave investors a brief overview of Nutra Pharma’s progress during 2015, as well as its goals and expectations for the coming months.

“We have had a very busy year at Nutra Pharma,” Deitsch explained in the news release. “2015 has been an inflection year for the company, launching our first new product in over two years (Pet Pain-Away), allowing us to begin to get back into clinical research on our lead drug candidates and bringing our drug platform into focus with the granting of orphan designation for RPI-78M for the treatment of pediatric multiple sclerosis.”

Among the most exciting news for Nutra Pharma’s prospective investors was the company’s progress with its therapeutic drug pipeline. In September, the company received orphan status for drug candidate RPI-78M for the treatment of pediatric multiple sclerosis, an indication with no approved treatments currently on the market. In addition to clearing the way for reduced costs and an accelerated development timeline, orphan designation provides Nutra Pharma with a seven-year period of market exclusivity in the U.S. following FDA approval. In an effort to maximize the benefits of this program, the company has also applied for orphan status for RPI-78M for the treatment of Myasthenia Gravis (MG). After receiving this status, Nutra Pharma expects to initiate clinical trials by the end of 2016.

In addition to its work on the drug development front, Nutra Pharma continues to make progress toward expanding its retail distribution network for its over-the-counter products. Sales from Nyloxin and Pet Pain-Away are expected to bring in additional revenue for the company that will be essential to the financing of proposed clinical studies. Nutra Pharma has already announced plans to begin distribution of Nyloxin in Canada in the coming months, and the company has also received acceptance from CPAM, the medical authority in China, to expand its distribution network into the Asian nation.

By reinitiating clinical work for its lead drug candidates, RPI-MN and RPI-78M, Nutra Pharma is once again progressing toward its goal of marketing or licensing its drugs for the treatment of multiple sclerosis and HIV/AIDS. As it aims to meet its true potential in the bio-pharmaceutical space, the company represents an intriguing option for investors in the coming months.

The shareholder letter is available on the company’s website at http://www.nutrapharma.com/Dec2015_shareholder_letter.pdf

For more information on the company, visit www.NutraPharma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

OurPet’s Company (OPCO) Provides an Opportunity to Capitalize on the Steady Growth of the Pet Industry

The success of any growing business depends on a wide variety of factors, but few decisions can impact a company’s prospects for growth more than choosing the right industry or market niche in which to operate. In a recent article on Entrepreneur.com, Christina Baldassarre outlined the benefits of one of the most intriguing market sectors for investors on the hunt for long-term plays with huge upside – the pet industry.

There are plenty of distinguishers to keep in mind when studying an industry’s viability. Is it recession-proof? Is it predictable? Is it experiencing consistent growth? When it comes to the pet industry, the answers to these questions are overwhelmingly positive. In the Entrepreneur.com article, the author studied the effects of the recent recession on the pet industry by taking an in-depth look at Google Trends for the search terms ‘dog toys’ and ‘cat toys’ over the past decade. Interest in both phrases maintained a consistent pattern throughout the 10-year period, with searches spiking toward the holiday season each year.

Overall, industry statistics support Google’s (NASDAQ: GOOG, GOOGL) data. Over the past 20 years, the domestic pet market has more than tripled in size, growing from $17 billion in 1994 to just over $60 billion this year, according to the American Pet Products Association. Among these expenditures, just over 25 percent were attributed to veterinary care, leaving nearly three-quarters of the total pet industry divided amongst retailers and service businesses. For companies operating in this space, there’s plenty of room for financial growth. Most retail businesses seek margins of approximately 60 percent or more, but some of the most popular pet toys and bones offer margins in excess of 70 percent.

With an expansive and consistent market and an educated customer base, it’s surprising to find that the pet industry is comparatively sparse when it comes to pure plays. Currently, the industry is extremely fragmented, with hundreds of small, relatively unknown brands jostling for a piece of the growing pie. However, one company, OurPet’s Company (OTCQX: OPCO), has been building a strong presence in the market for nearly two decades.

OPCO’s business model centers on marketing products designed to satisfy the mental and physical health, safety and comfort of pets around the world. The company is already a significant player in domestic sales of bowls/feeders; cat and dog toys and accessories; and feline waste management solutions. OPCO’s distribution network includes agreements with some of the most recognizable retail brands in the world – including PetSmart, Kroger (NYSE: KR), Walmart (NYSE: WMT) and Amazon (NASDAQ: AMZN).

With a growing foothold in the third largest consumer market in the country and an expanding portfolio of more than 1,500 SKU’s and 225 patents, OPCO represents an intriguing investment option that a contributor to Seeking Alpha recently referred to as “one of the only non-retail pure pet plays left in the industry.” As the company makes efforts to increase its brand awareness by targeting dedicated shelf space in retail stores, it could be primed to continue building on its past growth while promoting strong, sustainable returns for shareholders.

For more information, visit the company’s website at www.ourpets.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

The Bowser Report – Daily Mover Alert December 29

Today, The Bowser Report issued a daily mover alert on DLH Holdings (DLHC) and Where Food Comes From (WFCF), both of which gained more than 10% today, as well as Direct Insite (DIRI), which fell more than 10% today.

DLHC has now set a new 52-week high on back to back days. Previously, its yearly high was $3.50 set on July 2, 2015. Yesterday, as we mentioned, it hit $3.75, before resetting the bar at $4.47 today. Over the past month, DLHC has had a very positive trend, appreciating 61% during that period.

Well above $3 per share, DLHC is out of our buying range. For those holding, be sure to keep an eye on your double price, or even set a limit order just in case. Remember the Game Plan: sell half at the double and the remainder after it falls 25% from its most recent high (currently $4.47).

WFCF’s stock price was trading at a 52-week low one week before Christmas. However, with today’s movement included, the shares have bounced nicely off that bottom. Still, the stock has been trending down for a while and there’s not definitive proof of a long-term turnaround.

With a Bowser Rating of 7, WFCF is not “buyable.” Revenues have continued to grow, but earnings have yet to find a footing. One quarter they’re up, the next they’re down. Nine-month net income is up 131%, but net income was down slightly in the third quarter.

While not rated high enough to buy now, WFCF is one to watch if you don’t already own shares. The company’s niche and business model make for an interesting investment, and more than likely a profitable one if earnings can show any consistency on a month-to-month basis.

Yesterday we said that volatility is the norm for DIRI, and here is another instance of that. Up over 10% yesterday, down over 20% today. Clearly someone saw yesterday’s gain on light volume as an opportunity to sell as large volume accompanied today’s slide.

Once again, DIRI has a Bowser Rating of 8, which makes the company “buyable.” Still, we think this is a speculative buy, even at these low prices, because of the company’s volatile tendencies and inconsistent financials.

To learn more about The Bowser Report, visit https://thebowserreport.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Tuesday, December 29, 2015

Nutra Pharma Corp. (NPHC) is Doing Things Differently in the Biotech Industry

Nutra Pharma Corp. (OTCQB: NPHC) is introducing new healthcare solutions to the globe. Through ReceptoPharm, a subsidiary, Nutra Pharma is discovering, researching and developing biopharmaceutical products to prevent and/or treat multiple sclerosis (MS), HIV/AIDS, adrenomyeloneuropathy (ADM), herpes, rheumatoid arthritis and pain.

Drug Discovery & Development

Nutra Pharma is in the business of acquiring, licensing and commercializing pharmaceutical products and technologies, along with homeopathic and ethical drugs for managing pain and neurological disorders, autoimmune and infectious diseases and cancer.

The company has several pipeline products both in the market and under research and development. Within the over-the-counter pain management market, Nutra Pharma is already marketing:

Nyloxin and Nyloxin Extra Strength, homeopathic drugs used to alleviate moderate to severe chronic pain; and
Pet Pain-Away, a homeopathic, non-addictive, non-narcotic pain reliever aimed at treating moderate to severe chronic pain in companion animals.

Nutra Pharma also has more than a few novel therapies in various stages of development, including:

·         Nyloxin Military Strength, a pain relieving drug intended for sale to the U.S. Military and Veteran's Administration;
·         RPI-MN, a drug designed to treat viral diseases, such as HIV/AIDS and herpes;
·         RPI-78, which is geared toward managing pain and arthritis;
·         RPI-70, another pain reliever;
·         Equine Nyloxin, a topical therapy for horses; and
·         RPI-78M, which is designed to treat neurological diseases and autoimmune diseases, including MS, ADM and rheumatoid arthritis.
·          
Through RPI-78M, Nutra Pharma reached new heights this year. In September, the U.S. Food and Drug Administration granted RPI-78M "orphan drug status" for the treatment of multiple sclerosis in children - a major milestone for the company. Not only is juvenile MS an important disease area, but it is one that is not being addressed by other drugs currently on the market. This creates a significant market opportunity for Nutra Pharma, as does the designation of RPI-78M as an orphan drug. With that label, Nutra Pharma has a 7-year period of market exclusivity in the U.S. once the drug is approved, and, based on its pre-clinical and open-label studies, the company feels quite strongly that it has the ability to successfully pass through this approval process.

For more information on the company, visit www.NutraPharma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

GTX Corp. (GTXO) Offers Team Tracking App to Enhance Business Management

GTX Corp. (OTC: GTXO) has been at the forefront of 2-way GPS real-time personal location services since it went public in 2008. Since then, it has introduced miniaturized GPS, BLE, and cellular tracking technology that minimizes power consumption. These services and devices can monitor and locate people, pets, vehicles, and more. Headquartered in Los Angeles and with distributors in over thirteen countries, GTX provides end-to-end solutions and hardware that is fully customizable and boasts a user-friendly experience for clients.

In 2008, GTX created Track My Workforce, a managing system application designed for small- to medium-sized companies that allows a closer inspection of worker operations, such as delivery of products. So far, industries like pharmaceutical, food, consumer goods, jewelry, plumbing, and construction have benefited from this cost-effective solution. Track My Workforce maintains its mission of giving “the highest level of tracking and monitoring technology, products, and services” while providing “excellence in customer satisfaction.”

The Track My Workforce application is easily downloadable on both iOS and Android devices without the need to purchase new hardware. The app works silently in the background on a worker’s phone so he/she can still use other apps without draining the battery. Meanwhile, the worker’s whereabouts are updated at customizable intervals via GPS and viewable through the Track My Workforce website. Alerts are also automatically sent to the subscriber when a worker has arrived/departed from a designated geozone, such as a customer’s location. The application then makes mileage reports available to compare time management of workers, which can lead to cost-saving changes.

GTX aims to continue delivering its award-winning GPS SmartSole, along with its top-selling Smartphone Apps, to both new and loyal customers. The company intends to provide, innovate, and expand upon its tried and true services throughout the world.

For more information, visit www.gtxcorp.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Giggles N’ Hugs, Inc. (GIGL) Encouraging Repeat Customers with Intriguing Membership Program

When combining a traditional restaurant concept with the excitement of innovative entertainment options, membership programs and value cards can make a huge difference to a company’s bottom line. To illustrate this fact, one needs look no further than Dave and Buster’s Entertainment, Inc. (NASDAQ: PLAY), the growing force behind one of the most popular dining and entertainment chains for adults and families in North America. Since opening its first location in 1982, Dave & Buster’s has grown into a national phenomenon, operating 73 locations across the United States.

Today, the Dave & Buster’s brand is synonymous with good times, and that’s because of PLAY’s ability to evolve and adapt with changing consumer demand. One of the best examples of this evolution was the introduction of PLAY’s pioneering rechargeable Power Cards. When diners want to enjoy a few arcade games at their local Dave & Buster’s, fumbling with cash or coins never gets in the way of the fun thanks to these reloadable cards. While this model offers convenience for customers, it also promotes repeat visits by storing deposited funds for use on the next visit.

Although Dave & Buster’s is one of the most recognizable brands in the food and entertainment space to implement a rewards card-based customer retention strategy, it’s far from the only restaurant chain capitalizing on this proven tool. Giggles N’ Hugs, Inc. (OTCQB: GIGL) – the first and only known restaurant brand that brings together high-end, organic food with active, cutting-edge play and entertainment for children – has implemented a similar model to build upon the early successes of its three locations in Greater Los Angeles.

The GIGL membership program allows parents to minimize the cost of visits to Giggles N’ Hugs locations by purchasing unlimited play passes for one-, three- or six-month intervals. For less than the cost of four visits, GIGL members can enjoy unlimited visits for a full month, and additional savings are offered for families with multiple children. To sweeten the deal, the company often offers additional benefits – including discounts on food and beverage purchases and birthday parties. This program encourages repeat visits for the company’s customers and, as a result, bolstered financial growth for GIGL.

Just in time for the holiday season, GIGL also offers gift cards, which can be purchased directly through the company’s website. By offering membership specials and other promotional deals, GIGL is in a favorable position to maintain its status as Los Angeles’s #1 Family Restaurant. As the company seeks to expand upon its national footprint in the coming months, look for this proven branding strategy to play a key role in GIGL’s efforts to promote sustainable growth.

For more information, please visit www.gigglesnhugs.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

The Bowser Report – Daily Mover Alert December 28, 2015

Today, The Bowser Report issued a daily mover alert on Direct Insite (DIRI) and InfoSonics (IFON), both of which gained more than 10% today.

Volatility is the norm for DIRI. The company averages just 2,419 shares traded per day over the past three months. At a price per share of less than $1, big moves occur relatively often.

Currently, DIRI has a Bowser Rating of 8, which puts the company in Category 2. At this low price, it might be considering adding a DIRI position. However, the company’s financials have been less consistent recently. So, approach this one as a more speculative buy.

On average volume, IFON made a large move today, especially towards the end of the day. The stock has been trending down since its most recent quarterly report caused a spike in price per share.

That quarterly report moved IFON from Category 3 to Category 1 with a Bowser Rating of 10. The company has established a trend of good earnings reports, followed by an off quarter. Then, the company recovers and the stock soars. That sequence has happened twice now since we’ve recommended IFON.

Picking up shares at lower prices levels while the company has a high rating is a good idea. If an off quarter arises, there is a floor. If more solid quarters come, sky is the limit.

To learn more about The Bowser Report, visit https://thebowserreport.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Monday, December 28, 2015

OurPet’s Company (OPCO) Targeting Significant Market Growth with Investment in Distribution and Marketing Infrastructure

Anatole France, who won the Nobel Prize for Literature in 1921, famously said, “Until one has loved an animal, a part of one’s soul remains unawakened.” We know how true that is, because we do love our animals. In Pet Population & Ownership Trends (November 2014), the market research company Packaged Facts reported that about 55% of the U.S. adult population (133 million people) has at least one pet. Dogs are our favorites. There are 45 million households with man’s best friend. Another 30 million or so of us own (or are owned by) a cat. Then, there are the almost 7 million who love fish and the 4 million who fly with the birds and even some 3.5 million who own a reptile.

The American Pet Products Association (APPA) estimates that U.S. pet industry spending will be about $60.59 billion this year. Most of this, some $23.04 billion, will go toward food, of course. The vet will get about one-quarter of that, or $15.73 billion. Another $14.39 billion will go for over-the-counter medicines and supplies. Keeping our pets in a safe place while we go away and grooming services will cost us another $5.24 billion, and getting new pets will involve an investment of $2.19 billion. The industry has grown at an annually compounded rate of 4.6% over the past five years, from $48.35 billion at the end of 2010 to the 2015 estimate of $60.59 billion.

There are a number of factors underpinning this market expansion. First, the industry has been successful in emphasizing the bond we have with our pets. The typical American regards his dog or cat as a member of the family. This has driven sales of top-end products. Second, many upper-income households spend heavily on pet care products, such as toys and other devices that cater to their pet’s mental well-being. Third, the participation of upper-income households in the market has spurred the development of the pet specialty channel, which caters to more esoteric products. Finally, the recognition that pets, like us, need specialized health care has given rise to a burgeoning market.

Despite favorable market conditions, opportunities to invest in this lucrative industry are limited. Most companies in pet care and supplies, save a few, are private. Apart from the big dogs like PetSmart, Inc (NASDAQ: PETM) and Central Garden & Pet (NASDAQ: CENT), there’s very little else on the big exchanges.

There is, however, an oasis in this desert of investment opportunities. OurPet’s Company (OTCQX: OPCO) has been growing much faster than the industry. Since 2010, it has recorded a compound annual growth rate of about 6%. In 2011, it initiated a two-pronged branding strategy. The OurPet’s brand is aimed at the pet aficionado, while the Pet Zone brand is designed for the mass market. This strategy has, undoubtedly, paid off.

The management team is ambitious. In a recent interview, they confessed their objective to double the size of the company. As part of that initiative, they are investing heavily in distribution and marketing infrastructure. Also, they plan to make the waste and odor category a more significant part of OPCO’s business. Spearheading this thrust is the Smart Scoop product line. OPCO’s strategic business plan calls for annual year over year sales growth of 20% with targeted net income as a percentage of sales in the 10% – 12% range. Looks like the guys at OPCO plan to make investors purr.

For more information, visit the company’s website at www.ourpets.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

International Stem Cell Corp. (ISCO) Edges Ever Closer to First Real Therapeutic Solution for Halting & Even Reversing Parkinson’s

With the recent announcement from Australia’s version of the FDA, the Therapeutic Goods Administration, that pluripotent stem cell manufacturing innovator International Stem Cell Corp. (OTCQB: ISCO) has been cleared to start Phase I/IIa dose escalation clinical trials focused on the safety and efficacy of its human parthenogenetic neural stem cells (ISC-hpNSCs), the company has taken another major step toward a real therapeutic solution to Parkinson’s disease. An incurable condition that primarily affects the planet’s growing elderly population, Parkinson’s currently afflicts well over 10 million people worldwide and represents a therapeutics market somewhere in the neighborhood of $2.6 billion.

However, while the sale of extant therapeutics will continue to be dominated by mere dopamine agonists and an increasing use of MAO-B inhibitors (historically used to treat depression), such treatments are palliative at best, and sales will be substantially impacted by the rapid proliferation of generics. Even the newer agents coming down the industry’s pipeline through to 2020, such as a reformulated levodopa from Impax Laboratories (NASDAQ: IPXL) and GlaxoSmithKline (NYSE: GSK), or the MAO-B inhibitor safinamide being developed by Merck (NYSE: MRK), Newron (OTC: NWPHF) and EMD Serono, will be forced to compete with generics.

ISCO, on the other hand, has the inside track in this market with an injectable cellular therapy that is potentially capable of actually replacing dead and dying neurons in the midbrain, while directly offsetting Parkinson’s symptoms. This solution also offers substantial protection to surviving neurons, shielding them from further deterioration. Considerable pre-clinical animal model testing has already shown extremely promising results and the progress ISCO is set to make via the Phase I/IIa clinical trial in humans could propel the company to stardom as the first to develop an actual solution for Parkinson’s sufferers.

This same technology, because it employs high purity functional adult human cells that have been created from unfertilized donor eggs at the company’s state-of-the-art Oceanside, California, facility using an ethical, patented chemical differentiation process, could also evolve into frontline treatments for other CNS (central nervous system) maladies such as Alzheimer’s and stroke. The FDA’s recent IND approval of Stemedica’s allogeneic (same species but genetically dissimilar and generally immunologically incompatible) stem-cell therapy for a Phase IIa clinical study in Alzheimer’s at UC San Diego shows how much potential there is for this kind of technology, and how receptive the FDA has become to stem cell technology.

ISCO’s ability to manufacture commercial-scale batches of both precisely human leukocyte antigen-matched (HLA) and therefore histocompatible human parthenogenetic stem cell lines, as well as HLA-homozygous lines that are suitable for significant segments of the overall population, gives the company a real edge here as well. Stemedica’s allogeneic stem cells, for instance and by contrast, are cultivated from donor tissues, not differentiated from unfertilized eggs. Thus, ISCO’s technology is quite remarkable, because it substantially overcomes one of the main challenges facing stem cell therapeutics as a viable solution to numerous diseases; namely, cell rejection by the patient’s immune system.

International Stem Cell Corporation could be first to market a treatment actually capable of halting the progression of Parkinson’s disease in its tracks, or even reversing the impact of the disease. Results from the company’s landmark human clinical trial should start to become available in the coming months and investors should keep a close eye on ISCO for breaking news.

For more information, visit www.internationalstemcell.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Freedom Leaf, Inc. (FRLF) is Designed Around Growth Vision of Founders

Freedom Leaf, a leading marketing and business resource for the cannabis, industrial hemp, and medical marijuana industries, has its roots in the vision of its founders, representing decades of experience in the marijuana legalization movement. The company does not handle, grow, sell, or dispense marijuana or related products, but rather is a movement marketing company bringing together a fast-growing industry and the public. It does this through a variety of media resources, providing news and industry information, while offering a range of business services, including marketing, advertising, and consulting, to help the many young companies in the industry develop.

In addition to Freedom Leaf’s popular Freedom Leaf magazine, now available in 32 states, the company is also growing on the Internet, with a number of current and developing online sites, all designed to help educate, advocate, and assist in the burgeoning industry:

•           FreedomLeaf.com
•           MarijuanaNews.com
•           LadyCannabis.com
•           Cannabis Business University
•           CannabisSeminars.com
•           CampusCannabisDebate.com
•           CannaSpa.com
•           Vegasterdam.com

According to the company, Freedom Leaf’s three essential areas of operation are:

1)         Licensing of brands, in which licensees can market and sell Freedom Leaf magazine, website advertising, products, services, seminars, musical festivals, and other branded products
2)         Acquiring and incubating new and existing businesses entering into the cannabis/hemp industry – ultimately purposed for spin-off
3)         Entering into branding, marketing, and promotion contracts, with both profit and non-profit organizations, for which Freedom Leaf has extensive and far-reaching promotional capabilities

In the words of the Freedom Leaf founders:

Richard Cowan (Founder) – “Freedom Leaf, the Marijuana Legalization Company, is focused on ending marijuana prohibition. But this is also an experiment in a new form of social – not just political – activism. We are combining the motivation of entrepreneurial spirit with a devotion to personal liberty. You can’t get more American than that!”

Clifford Perry (CEO, President, Co-Founder) – “The Freedom Leaf vision is to build brands associated with the legalization of marijuana. We are growing a marketing network from the roots up. Our goal is to support the movement. We are focused on advocacy and publishing stories that promote legalization, while appealing to the broader, non-consuming population at the same time.”

For more information, visit http://freedomleaf.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Monday, December 21, 2015

GTX Corp. (GTXO) Gives Peace of Mind to Alertag Wearers and Family Members in Case of a Medical Emergency

GTX Corp. (OTC: GTXO) provides GPS, cellular, and BLE solutions through wearable technology. The company believes in giving the global community tracking technology that empowers families and businesses to locate anyone they need. Not only does GTX Corp. deliver GPS solutions, it also markets a simpler, yet lifesaving product called Code Amber Alertag. This is a small tag that attaches to keychains and gives access to the wearer’s medical information in case of an emergency.

First responders are trained to look for the medical information of injured individuals upon arriving at the scene. Unfortunately, this important information is rarely found, which leads many people to suffer from preventable medical errors, the fifth leading cause of death in the United States. Fortunately, Alertag provides EMTs with a special code that can be entered into the IDAmber.com website in order to retrieve any medical information on allergies or pre-existing conditions that could help during an emergency.

Code Amber Alertag also offers multiple tiers of privacy protection for wearers. First, the security code on the back of the tag only gives public access to medical information such as allergies and chronic conditions. For a full medical history, a special key code is required that should be given to the wearer’s emergency contacts. The wearer also has a password to log in and edit any of this information. Alertag wearers can include any information they want when signing up, such as photos, documents, and contact information.

Interestingly, one out of four people have medical conditions that could complicate emergency treatments. Having this information on hand gives first responders the ability to quickly assess the situation and determine a proper treatment. Holding this product also helps when friends and family are too overwhelmed to recall pertinent health information during an emergency. Similarly, if an injured person is found alone, he/she may not be able to communicate these details.

GTX Corp. aims to cut down on the number of medical errors through its Code Amber Alertag, which can help children, adults, seniors, workers, and even animals.

For more information, visit www.gtxcorp.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

OurPet’s Company (OPCO) Represents a Model for Growth in Sales and Earnings

Small Cap companies represent unique and advantageous opportunities to get in on the ground floor of a company before it turns into the next Twitter (NYSE: TWTR) or Facebook (NASDAQ: FB). With a very small investment during the early growth stages, the return can be life changing. The trick is doing your due diligence and pulling the trigger on winners. Keys to look for are always fundamentals, sales growth and an increase in earnings. OurPet’s Company (OTC: OPCO) has all of the above and has been around since 1995.

In its first year of operation, OurPet’s reported annual sales of $150,000, more than tripled that number the next year to $500,000 and now boasts more than $25 million in annual sales. The company is also profitable and has shown growth in that area as well since 2011. Over that time period, OurPet’s earnings have grown from $120,674 to $1.1 million.

The pet products and services industry, where the company operates, was valued at $71.3 billion in 2013 and is expected to grow even more in the coming years. The company has more than 250 distribution customers, including household names like Wal-Mart (NYSE: WMT), PetSmart (NASDAQ: PETM), Petco and Kroger (NYSE: KR). Relationships like these are essential to sustaining and topping sales and earnings targets in the future.

Innovative and consistent product developments are very important, as well, particularly for companies in the pet products industry. Keeping things fresh and up to date for the ever-changing needs of the consumer is evident with OurPet’s business strategy, as they have about 30 new products in the mill for release during 2016 and beyond.

Consistency and innovation define the OurPet’s brand. Now that its brand is established, it is the company’s mission to gradually increase market share both domestic and internationally. With relationships already in place with world leaders like Wal-Mart, it’s only a matter of time before OurPet’s Company becomes a household name.

For more information, visit the company’s website at www.ourpets.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

How Oakridge Global Energy Solutions, Inc. (OGES) Excels at “Made in the USA” Manufacturing

Oakridge Global Energy Solutions, Inc. (OTC: OGES) is in the business of using top-of-the-line technology to manufacture highly innovative energy storage solutions across the United States. As a ‘Made in the USA’ manufacturing company, OGES’s strategy of execution is as simple as it is effective: develop, manufacture and sell products.

The company’s products include lithium-ion large format prismatic cells, small format prismatic cells, and battery modules, which are distributed through a highly focused business development and sales team. The company’s innovative ‘Made in the USA’ product line, comprised of multiple lithium-ion chemistries, technologies and form factors (or shapes) that address multiple high-demand target markets, is a stand-out offering in the manufacturing business that leads the onshoring movement of bringing jobs and manufacturing back to the USA.

Manufacturing products of this caliber calls for an equally high level of manufacturing capacity and sophistication. Through the majority ownership of Oakridge by Precept Fund Management SPC, Oakridge CEO Steve Barber funded the creation of a full-scale manufacturing facility for Oakridge, a significant upgrade from the company’s previous 12,500-square-foot-facility.

In October, Oakridge unveiled the new, 68,718-square-foot facility in Brevard County, Florida, in Melbourne and Palm Bay. The sprawling plant houses Oakridge’s corporate offices and manufacturing plant, and it is part of the company’s ongoing $270 million investment in corporate growth, which also includes the planned purchase of a significant amount of additional manufacturing equipment, as well as continued product development and innovation.

Precept’s investment in Oakridge’s facility has already triggered a positive effect, contributing to the company’s third-quarter results (total assets exceeded $76.0 million while liabilities were reported at slightly more than $2.75 million).

“Our third-quarter results reflect the significant investment that Precept has made into this exciting business,” said Barber. “From development of products to purchase of manufacturing equipment, this business is now fully operational and poised for growth.”

Over the next 18 months, Oakridge has outlined plans to continue to strengthen its balance sheet and ramp-up and install more than 2.6 gigawatt-hours of production capacity. The focus of the ramp-up and installation will be on manufacturing electrodes, cells and batteries in the company’s new facility.

For more information, visit www.oakg.net

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Friday, December 18, 2015

Giggles N’ Hugs, Inc. (GIGL) Positioning Itself for National Expansion in 2016

For months, Giggles N’ Hugs, Inc. (OTC: GIGL) has been making moves to better position itself for financial growth. Leveraging the marketability of its innovative family-friendly restaurant and play center concept, the company has garnered interest from both mall owners and franchisees regarding both national and international expansion. In October, GIGL gave the investment community some insight into this interest when it announced that Westfield Corp. (OTC: WEFIF), one of the world’s leading shopping center operators, had reached out to the company about expanding upon their current partnership. According to Joey Parsi, founder and chief executive officer of GIGL, interest from Westfield may be just the tip of the iceberg.

“With the unbelievable management team we now have in place, and having one of the most unique concepts in the restaurant industry, as well as the deals and opportunities we are getting from Westfield and all the other major mall owners, we are ready to explode onto the national scene first with multiple locations in some of the best properties in the country and ultimately around the world,” Parsi stated in a news release.

Currently, GIGL owns and operates three locations in the Greater Los Angeles area, including two locations in Westfield malls, but the company has recently turned much of its attention toward expanding its footprint around the country, especially along the West Coast. Earlier this month, GIGL took a major step toward turning that goal into a reality when it signed an agreement with New York-based Chardan Capital Markets, LLC. Under the terms of this agreement, the boutique investment bank will introduce GIGL to potential investors and business partners, advise and assist management in preparing for presentations to financial sources and perform a wide variety of financial advisory services.

This partnership is particularly interesting for GIGL’s prospective shareholders, because Chardan specializes in providing a range of investment services to micro-cap emerging growth companies. The bank has become a leader in the securement of capital solutions for these companies, raising in excess of $13 billion through more than 250 transactions.

“As we continue to grow and expand our reach in markets throughout the country and the world, we look forward to working with Chardan to assist in taking our company to the next level,” continued Parsi.

With a proven concept, mounting interest from some of the world’s largest mall operators and a partnership with one of the country’s most successful investment banks focused on servicing micro-cap companies, GIGL could be on the cusp of a period of considerable growth. As the company seeks to begin taking the necessary steps to uplist to a national exchange during 2016, GIGL is emerging as one of the hospitality sector’s most intriguing investment options.

For more information, please visit www.gigglesnhugs.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Nutra Pharma Corporation (NPHC) Targeting Underserved Pharmaceutical Indications with Proprietary Therapeutic Protein Products

Nutra Pharma Corporation (OTC: NPHC) is a biotechnology company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. The company’s product portfolio includes Cobroxin, the first over-the-counter pain reliever clinically proven to treat moderate to severe chronic pain, and Nyloxin, the only non-narcotic and non-addictive treatment for severe pain. Both products were developed by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm.

Currently, ReceptoPharm is developing proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases by leveraging the specialized receptor-binding proteins found in nature, particularly those found in cobra venom. The company’s leading drug candidates, RPI-MN and RPI-78M, are being developed for the treatment of HIV and multiple sclerosis, respectively. By leveraging a proprietary chemical process, ReceptoPharm is able to create drugs that possess a host of desirable properties – including lack of toxicity (which eliminates the threat of overdosing), extended shelf life and total absence of serious adverse side effects.

Earlier this month, Nutra Pharma took a significant step in the development of RPI-78M when it announced that it had applied for an orphan drug designation from the U.S. Food and Drug Administration for the treatment of Myasthenia Gravis (MG). If received, this would be the company’s second orphan drug designation approved in recent weeks. In September, Nutra Pharma was granted the designation for the treatment of Pediatric Multiple Sclerosis (MS).

Orphan drug designations are designed to encourage the development of drugs which may provide significant benefits to patients suffering from rare diseases. For pharmaceutical companies, the program offers a seven-year period of market exclusivity, as well as tax credits and, in many cases, grant funding to cover a portion of clinical research costs.

“We have been clear over the last year that we would be moving our drug platforms forward,” Rik J. Deitsch, chairman and chief executive officer of Nutra Pharma, stated in a news release. “This includes our work in Pediatric Multiple Sclerosis as well as additional potential orphan designations for our therapeutic pipeline.”

Although MS most commonly occurs in adults, it also effects an estimated 10,000 children in the U.S., according to the National Multiple Sclerosis Society. There are currently no approved treatments for pediatric MS. Instead, FDA-approved self-injectable disease-modifying therapies developed for use in adults are often used ‘off-label’ in children. Large clinical trials are still needed to assess the treatment efficacy of these therapies in the pediatric population, making a therapeutic designed and tested specifically to treat pediatric MS a potential game changer moving forward.

For more information on the company, visit www.NutraPharma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Latitude 360 (LATX) Adds the Intrigue of Fantasy Sports to its Smorgasbord of Entertainment Delights

Latitude 360 (OTC: LATX) is surfing the wave of an industry that, according to a recent study, is growing at over 16% per annum and has been maintaining that rate over the past five years. The company is an award-winning, full-service upscale restaurant and leisure emporium that plans, develops, constructs and operates premier entertainment venues. At present it operates three such locations. The first was opened in January 2011 in Jacksonville, Florida; the second in November 2012 in Pittsburgh, Pennsylvania, and the third in Indianapolis in January 2013. The company plans to open three more locations. The first of these is slated for Syracuse at Destiny USA, the largest shopping center in the state of New York.

Latitude 360’s menu of entertainment options at its three locations includes a main restaurant (360 Grille & Bar), a luxury bowling alley (The Lanes), a dine-in movie theater (Cinegrille), a game room offering the latest hi-tech video and redemption games, a theater for live performances (Latitude Live), a sports theater with multiple HD screens, a luxury smoking lounge (Latitude Lit), and a dance arena (Axis Bar & Stage).

Latitude 360 is promoting a seminal idea. It aims to redefine the modern American entertainment experience by altering the mix and variety of entertainment options available at one venue. Latitude 360 is the Disneyland for adults. The company’s strategy is to create a one-stop entertainment shop where dining facilities, the movies, bowling, gaming, live entertainment or a sports bar can be found. The company recently launched its latest product offering, 360 Fantasy Live, in the highly lucrative fantasy sports market.

Fantasy sports allow sports fans to bet on the performance of their favorite players. Fantasy sports are fast becoming the sports fan’s stock market, since every fan that knows and loves his football can now put his knowledge to the test. The Fantasy Sports Trade Association (FSTA) reports that, currently, there are close to 57 million players of fantasy sports in the U.S. and Canada, each of whom spends, on average, $465 per year. That amounts to roughly $26.5 billion. The customer base for fantasy sports, according to the FSTA, has been growing at an annual compounded rate (CAGR), from 2010 to 2015, of over 12%. The typical fantasy sports player is male, around 37, and college educated, and about half earn more than $75,000. The industry has yet to realize its potential. It is now moving into sports other than football.

For more information on the company visit www.latitude360.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Thursday, December 17, 2015

It’s Old Heads on Young Shoulders at Legacy Ventures International, Inc. (LGYV)

An enduring expression tells us ‘you can’t put an old head on young shoulders’, meaning we shouldn’t expect someone young to have the wisdom and maturity associated with older folk, but Legacy Ventures International, Inc. (OTC: LGYV) has turned that time-honored saying on its head. The company, indeed, has young shoulders. It was incorporated in Nevada on March 4, 2014, but its management team is full of experience in start-ups, business development, branding, distribution, retail sales and strategic planning. Legacy Ventures is focused on the acquisition of proven and high-potential businesses across a variety of business sectors. Through the strategic provision of capital and oversight to companies that have innovative products, category game changers and established fast growth brands, Legacy Ventures aims not only to add shareholder value, but to make the world a better place to live.

A good example is its first major acquisition, RM Fresh Brands, which holds the rights to distribute Boxed Water in Canada. Boxed Water is a trendy new product that is expected to have an enthusiastic response from green consumers: those who prefer products that have been produced in a way that protects the natural environment. Boxed Water is environmentally friendly. It is packaged in a biodegradable carton that is 76% paper and has less than half the carbon footprint of the now ubiquitous polyethylene terephthalate (PET) bottle.

Evan Clifford is CEO at Legacy Ventures. Over the last 15 years he has had his fingers in many pies. He has, at one time, managed the careers of singer and songwriter Danny Fernandes, as well as Alicia Josipovic, who played Bianca DeSousa in the Canadian TV series Degrassi. He has been a concert producer. He co-founded Just Sushi, the world’s first 100% sustainable Ocean Wise sushi restaurant, and he was a partner in Cirqus Nightclub, which garnered acclaim as one of the hottest nightclubs and patios in the west end of the Greater Toronto Area. Clifford loves disruptive game-changing technologies. He was an investor in the Zenn Motor Company, a Canadian company that previously developed electric vehicles. ZENN is an acronym for Zero Emissions No Noise. He has been a speaker at the Idea City Conference, which is a sort of North American Davos for artists, authors, cosmologists, designers, entertainers, filmmakers, inventors, musicians, scientists and technologists. He was owner and Creative Director at Toy Box Events, ‘Where Imagination Comes to Life‘. He also served as a director at Golden Cross Resources, which engages in the acquisition, exploration, and development of mineral properties in Canada.

Matthew Merson is a director at Legacy Ventures. Merson has spent the last 25 years in senior executive positions at Dannon Yogurt, Sara Lee, Glaceau Vitaminwater, Coca-Cola (NYSE: KO), Aramark (NYSE: ARMK), and ZICO Beverages. He is currently the vice president of sales at Boxed Water is Better, LLC. For the last decade. Merson has specialized in the start up space for emerging brands that are disrupting the norm or creating entirely new categories. He thrives on building teams that can bring brands to life across all channels of sales, and he has expertise in all functional business areas – including operations, finance, marketing, human resources and international sales.

Mirwan Ferris is the brand broker at Legacy. Ferris, along with his brother Ameen, built the very successful retail chain Healthy’s Nutrition, which they later sold to Planet Organic Health Corp. Ferris then purchased Excel Marketing, later re-named Ex-L Brand Management, which represented and distributed ZICO Coconut Water, Hugo Naturals and many other popular brands. In 2011, he sold Ex-L Brand Management, and started a new brokerage firm, Ferris Brand Management. Ferris has experience in the Canadian retail market and the knowledge and skills to effectively navigate its distribution network.

Ron Patel is president of Legacy’s subsidiary, RM Fresh Brands, which markets Boxed Water. Patel has extensive experience in third party logistics and procurement. Over the years, he has been involved in the sourcing of over 10,000 different products for some of the largest U.S. and Canadian Military Prime Vendors. His focus has been in worldwide sourcing capabilities, purchasing and consolidation. In the last few years, Patel has been working with the Canadian and U.S. product landscapes and has developed alliances with hundreds of distribution, manufacturing and retail operations.

Rehan Saeed is chairman of the board at Legacy Ventures. Saeed has over 10 years of diverse experience across multiple verticals in the banking industry. As the acting CFO of a start-up (UMF), he built and managed a $110 Million real estate portfolio within 2 years. Later, he joined AYA Financial as vice president and brought in over $30 Million in revenue and increased profitability by 25% above the competition. Saeed teaches investments and finance at Centennial College Toronto and acts as a consultant to Bay Street law firms structuring specialty financing contracts for their institutional clients. Saeed has a bachelor’s degree in information technology (BA), a master’s in business administration (MBA) and is also a Certified Public Accountant (CPA).

Look out for Legacy Ventures. The company’s experienced leadership team is out to change the world.

For more information, visit www.legacyventuresinc.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Freedom Leaf, Inc. (FRLF) Conveys an Engaging Message about Marijuana Reform

Dubbed The Marijuana Legalization Company, Freedom Leaf, Inc. (OTC: FRLF) is a movement marketing business that highlights trending news about the cannabis industry through social media, in a print magazine and on the www.freedomleaf.com website.

Freedom Leaf’s founders are long-term cannabis advocates. Over the course of five decades, they have accumulated deep insights vital to the success of the legal marijuana industry and created brands pushing for the end of marijuana prohibition. With thousands considering legal marijuana one of the fastest-growing industries in the U.S., the founders have set up a clear and defined path for Freedom Leaf to share in the bounties of this mushrooming trade by continuously:

growing its broad suite of product and service offerings; and
refining its strategic distribution and licensing models.
As a leading marijuana-related news company, Freedom Leaf is engaged in multiple vertical and horizontal businesses – including branding, business development, education, entertainment, incubation, licensing, multi-media and public relations.

One of the company’s diverse services, Freedom Leaf Magazine, offers activists, consumers, entrepreneurs and patients a dependable way to stay on top of the latest marijuana-related information, innovations and legislation. The magazine reports on cannabis movements and their relationship to the law, politics, art, fashion, entertainment, finance, business, health and medicine. With a passionate flair and an engaging twist, the magazine chronicles stories related to the history of the cannabis industry with a focus on themes such as the fears of consumers during prohibition, growing and smuggling operations, incarceration, legislation and marijuana activism.

Freedom Leaf’s publications and products are conceived for empowerment. They are designed by and for cannabis activists, as well as other like-minded individuals, in the U.S. and around the world. They make it possible for those involved in the cannabis movement to build a career in freedom (by marketing Freedom Leaf’s products and services). To date, Freedom Leaf has published and distributed 10 editions and hundreds of thousands of copies of its magazine in over 30 states thanks to the backing of more than 150 activist marketers.

For more information, visit http://freedomleaf.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net


Moxian Inc. (MOXC) Boasts Rapid Corporate Growth along with a Strong Management Team

Moxian, Inc. (OTC: MOXC) provides social marketing and promotional platforms for clients who want to promote their businesses through social media. These clients can run advertising and promotional campaigns while gaining access to consumer behavior data compiled from a database provided by the company through Moxian+, their social media platform. For consumers, Moxian+ is a great way to see what special events and promotions are going on nearby. They can also play games, message friends, and shop at an online mall with virtual currency, all while racking up rewards points. Businesses using the platform can study analytics, use business and marketing tools geared toward customer needs, and advertise their services. In a social media-driven world, Moxian is providing an integrated platform that aims to pinpoint consumer behavior so businesses can take advantage and make a profit.

Behind the scenes, the management team of Moxian is filled with experience, intelligence, and creativity. At the forefront is CEO and chairman, James Mengdong Tan, who has over twenty years experience in private and public company management in both Asia and the United States. His work history includes being the chairman and CEO of Vashion Group, executive director and CEO of Vantage Corporation, and serving on the board of Pacific Internet Ltd. Tan graduated from the prestigious National University of Singapore in 1985.

Another impressive team member is Director Liew Kwong Yeow, who has over twenty-five years experience in senior positions related to the quality, procurement, and engineering of products. Past employers include Matsushita Denki, General Motors (NYSE: GM), and Intel (NASDAQ: INTC). He holds degrees and certifications from Singapore Polytechnics University, Intel University, and the General Motors Institute.

The Director of Creative and Marketing, Edmund Ooi, brings two decades of creative development and managing experience to Moxian. He helped the company increase its drive in China with his vast marketing communication and creative skills. In the past, Ooi has helped generate the sales and marketing strategies of Samsung (OTC: SSNLF), Apple (NASDAQ: AAPL), Mercedes, Warner Bros. (NYSE: TWX), and more.

Moxian intends to consistently improve its product while expanding its reach to include a wider audience. In a recent news release, Ooi stated, “I think we have seen a great leap in our skillset and our ability to offer much stronger and more robust software.”

For more information, visit the company’s website at http://ir.moxian.com/html-en/

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net